EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma

Ayushi Agarwal, Vishakha Tanna, Vijitha S Vempuluru, Vishal Raval, Swathi Kaliki

Ophthalmology Retina · 2025-06 · 9 (6) · 589-597

DOI: 10.1016/j.oret.2024.11.010 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Ophthalmology Retina, 2025-06. Verfasst von Ayushi Agarwal und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Topotecan, Retinoblastoma, Melphalan, Retinal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Operation Eyesight Universal Institute for Eye Cancer, Hyderabad Eye Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TopotecanRetinoblastomaMelphalanRetinal NeoplasmsVitreous BodyNeoplasm SeedingHumansIntravitreal InjectionsRetrospective StudiesFemaleMaleInfantChild, PreschoolTopoisomerase I InhibitorsIndiaFollow-Up StudiesAntineoplastic Agents, AlkylatingChild

Stichwörter der Autor:innen

Intravitreal chemotherapyMelphalanRetinoblastomaTopotecanVitreous seeds

Substanzen

TopotecanMelphalanTopoisomerase I InhibitorsAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India.
  • The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, Telangana, India. Electronic address: kalikiswathi@yahoo.com.

Förderung

  • Operation Eyesight Universal Institute for Eye Cancer
  • Hyderabad Eye Research Foundation

Zitieren

APA

Agarwal, A., Tanna, V., Vempuluru, V. S., Raval, V., & Kaliki, S. (2025). Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma. Ophthalmology Retina, 9(6), 589-597. https://doi.org/10.1016/j.oret.2024.11.010

Vancouver

Agarwal A, Tanna V, Vempuluru VS, Raval V, Kaliki S. Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma. Ophthalmology Retina. 2025;9(6):589-597. doi:10.1016/j.oret.2024.11.010

BibTeX
@article{Agarwal2025,
  author = {Agarwal, Ayushi and Tanna, Vishakha and Vempuluru, Vijitha S and Raval, Vishal and Kaliki, Swathi},
  title = {Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma},
  journal = {Ophthalmology Retina},
  year = {2025},
  volume = {9},
  number = {6},
  pages = {589--597},
  doi = {10.1016/j.oret.2024.11.010}
}
Kostenlos starten →